# MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More

- URL: https://theranews.net/blog/2026-05-26-medcheck-fda-approves-novel-antipsychotic-milsaperidone-designates-psilocybin-an-5820b7/
- Published: 2026-05-26
- Type: Archive summary (AI-assisted summary of third-party reporting)
- Original outlet: Psychiatry Online
- Original report: https://www.psychiatryonline.org/doi/full/10.1176/appi.pn.2026.04.4.3
- Topics: depression
- Publisher: TheraNews, operated by AdvancedCare USA Inc.
- Notice: Educational content, not medical, legal, billing or financial advice. Cite the original outlet, not this summary.

---
![MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More](/uploads/news-images/medcheck-fda-approves-novel-antipsychotic-milsape-20260526110108.jpeg)

.

---
*Originally reported by Psychiatry Online. [Read more](https://www.psychiatryonline.org/doi/full/10.1176/appi.pn.2026.04.4.3)*

---

*Source: [https://www.psychiatryonline.org/doi/full/10.1176/appi.pn.2026.04.4.3](https://www.psychiatryonline.org/doi/full/10.1176/appi.pn.2026.04.4.3)*